Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cottone

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Inflammatory Bowel Diseases|March 26, 2011
Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumabEmanuele Sinagra, Sara Renna, Filippo Mocciaro, et al.
Journal of Crohn'S & Colitis|July 10, 2012
An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: we are willing to take a risk of serious adverse events for a doubtful benefit?Emanuele Sinagra, Claudia Romano, Roberto Virdone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2013
Clinical implications of mucosal healing in the management of patients with inflammatory bowel diseaseAmbrogio Orlando, Francesco William Guglielmi, Mario Cottone, et al.
Inflammatory Bowel Diseases|December 28, 2018
Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-AnalysisFabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, et al.
Medical Hypotheses|September 3, 2013
Could growth hormone play a role in Peutz Jeghers syndrome?Emanuele Sinagra, Andrea Scalisi, Alessandra Santoro, et al.
Scandinavian Journal of Gastroenterology|September 7, 2019
Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohortFabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational studyFilippo Mocciaro, Sara Renna, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|October 8, 2008
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresisValeria Criscuoli, Filippo Mocciaro, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|January 29, 2005
Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enemaEmma Calabrese, Francesco La Seta, Antonio Buccellato, et al.
Annals of the Rheumatic Diseases|January 19, 2017
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel diseaseAmbrogio Orlando, Rosalba Orlando, Francesco Ciccia, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Inflammatory Bowel Diseases|March 26, 2011
Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumabEmanuele Sinagra, Sara Renna, Filippo Mocciaro, et al.
Journal of Crohn'S & Colitis|July 10, 2012
An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: we are willing to take a risk of serious adverse events for a doubtful benefit?Emanuele Sinagra, Claudia Romano, Roberto Virdone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2013
Clinical implications of mucosal healing in the management of patients with inflammatory bowel diseaseAmbrogio Orlando, Francesco William Guglielmi, Mario Cottone, et al.
Inflammatory Bowel Diseases|December 28, 2018
Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-AnalysisFabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, et al.
Medical Hypotheses|September 3, 2013
Could growth hormone play a role in Peutz Jeghers syndrome?Emanuele Sinagra, Andrea Scalisi, Alessandra Santoro, et al.
Scandinavian Journal of Gastroenterology|September 7, 2019
Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohortFabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational studyFilippo Mocciaro, Sara Renna, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|October 8, 2008
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresisValeria Criscuoli, Filippo Mocciaro, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|January 29, 2005
Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enemaEmma Calabrese, Francesco La Seta, Antonio Buccellato, et al.
Annals of the Rheumatic Diseases|January 19, 2017
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel diseaseAmbrogio Orlando, Rosalba Orlando, Francesco Ciccia, et al.
Pageof 12